Your browser doesn't support javascript.
loading
Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey.
Ishihara, Lianna; Beck, Melissa; Travis, Sara; Akintayo, Olusegun; Brickel, Neil.
Afiliação
  • Ishihara L; Department of Epidemiology, GlaxoSmithKline, Uxbridge, Middlesex, UK ; Lundbeck SAS, 37-45 Quai du President Roosevelt, 92130 Issy-les-Moulineaux, France.
  • Beck M; Regulated Healthcare Market Research, Concentrics Research LLC, Indianapolis, IN USA.
  • Travis S; Project Operations, Concentrics Research LLC, Indianapolis, IN USA.
  • Akintayo O; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex UK ; Apotex Inc., Toronto, Canada.
  • Brickel N; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex UK.
Drugs Real World Outcomes ; 2(4): 335-344, 2015.
Article em En | MEDLINE | ID: mdl-26690543
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article